AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2025
Sep 17, 2025
34187_dirs_2025-09-17_f616bf86-e1e9-4b00-aa32-51f645a47840.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-09-15
Reporting Person: Kester Thomas J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-15 | Common Stock | A | 37815 | — | Acquired | 458573 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-15 | Options to purchase common stock (right to buy) | $2.38 | A | 19041 | Acquired | 2027-09-15 | Common Stock (19041) | Direct |
Footnotes
F1: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025.
More from InspireMD, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2
Director's Dealing
2026
Feb 2